THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
Goal: to evaluate the efficacy and safety of domestic (home-produced) recombinant factor VIIa (Coagil VII) for massive bleeding and haemostasis disordes treatment in thoracic aorta surgery. Methods. 82 patients undergoing surgery on thoracic aorta with cardiopulmonary bypass and circulatory arrest s...
Saved in:
| Main Authors: | N. A. TREKOVA, D. A. GUSKOV, A. V. GONCHAROVA, B. A. AKSELROD |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2019-07-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII
by: Zeynep İnce, et al.
Published: (2018-10-01) -
Endovascular Management of the Ascending Aorta: State of the Art
by: Aidan D. Atkins, et al.
Published: (2023-03-01) -
The features of the mode of delivery in patients with congenital deficiency of coagulation factor VII: case reports
by: A. Yu. Bulanov, et al.
Published: (2020-12-01) -
Prevention of hemorrhagic complications during operations on the thoracic aorta
by: D. C. Panfilov, et al.
Published: (2018-12-01) -
El rey en el destierro: héroes y villanos en Memoirs of Ferdinand VII. King of the Spains
by: David Loyola López
Published: (2020-12-01)